RE:Looks like the buyers are goneHopefully once Q4 Earnings are posted we will see DCM increase its share value. The results in the stock spike at RRD are impressive once they announced Q4 and Full Year Earnings. While DCM continues to take out costs including the recent departure of Michael Cote, it will be interesting to see if this company can actually grow revenue going forward. It appears to me that a signficant amount of intellectual capital has left the organization over the years that had the business development skills to grow their core business. While their product range has increased through acquistions it is their core business of manufacturing products and services that needs to grow like Cannabis labels. Hopefully they continue to invest in products and services with CAGR Growth like their competitors. There really isn't much more to shed from DCM with respect to costs that will move the needle in any respect.